BioSpace News Archive

Viruses are minute organisms that are made up of genetic material and can cause infection in the body.

In its recent report, Transparency Market Research gives intricate details about the global behavioral health market.

AsclepiX Therapeutics, Inc., a clinical stage biopharmaceutical company using computational biology to identify potent peptide regulators of vascular and cellular homeostasis for the treatment of retinal and oncologic diseases, announced the appointment of Dr. Amir Shojaei as Chief Scientific Officer, Executive Vice President, Clinical Development.

Lucira Health, Inc., a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, commented on the recent recall of the FLOQSwabs by supply partner Copan Italia SPA, or Copan.

International Patent Filed Publication from the Hebrew University - Hadassah Medical Center Entitled: Augmented antiviral T cell immunity by oral administration of IMM-124E in preclinical models and a phase I/IIa clinical trial